Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cevoglitazar

Catalog No. T26986Cas No. 839673-52-8
Alias LBM-642, LBM642, LBM 642

Cevoglitazar (LBM-642) is a PPARɑ agonist and PPARγ agonist. Cevoglitazar potently reduces food intake and body weight in obese mice and cynomolgus monkeys.

Cevoglitazar

Cevoglitazar

Purity: 97.39%
Catalog No. T26986Alias LBM-642, LBM642, LBM 642Cas No. 839673-52-8
Cevoglitazar (LBM-642) is a PPARɑ agonist and PPARγ agonist. Cevoglitazar potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
Pack SizePriceAvailabilityQuantity
1 mg$108In Stock
5 mg$260In Stock
10 mg$390In Stock
25 mg$653In Stock
50 mg$928In Stock
100 mg$1,260In Stock
500 mg$2,530In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Cevoglitazar"

Select Batch
Purity:97.39%
ee:100%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Cevoglitazar (LBM-642) is a PPARɑ agonist and PPARγ agonist. Cevoglitazar potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
In vivo
Cevoglitazar (0.5 mg/kg; 7 d) plasma levels of glucose and insulin were normalized.[1]
Cevoglitazar (50 and 500 mg/kg; obese and insulin-resistant cynomolgus monkeys; 4 weeks) lowered food intake and body weight in a dose-dependent manner. In these animals, cevoglitazar also reduced fasting plasma insulin and, at the highest dose, reduced hemoglobin A1c levels by 0.4%.[1]
Cevoglitazar (5 mg/kg) reduced BW gain and adiposity, independent of food intake. In the muscle, cevoglitazar improves the lipid profile via both PPARalpha- and PPARgamma-mediated mechanisms, and cevoglitazar reduced hepatic lipid concentration below baseline levels (p < 0.05). Metabolic profiling showed that in the liver, cevoglitazar functions largely through PPARalpha agonism resulting in increased beta-oxidation. Cevoglitazar only induced small changes to the lipid composition of visceral fat.[2]
AliasLBM-642, LBM642, LBM 642
Chemical Properties
Molecular Weight558.53
FormulaC27H21F3N2O6S
Cas No.839673-52-8
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (89.52 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7904 mL8.9521 mL17.9041 mL89.5207 mL
5 mM0.3581 mL1.7904 mL3.5808 mL17.9041 mL
10 mM0.1790 mL0.8952 mL1.7904 mL8.9521 mL
20 mM0.0895 mL0.4476 mL0.8952 mL4.4760 mL
50 mM0.0358 mL0.1790 mL0.3581 mL1.7904 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cevoglitazar | purchase Cevoglitazar | Cevoglitazar cost | order Cevoglitazar | Cevoglitazar chemical structure | Cevoglitazar in vivo | Cevoglitazar formula | Cevoglitazar molecular weight